Edgewise Therapeutics, Inc.’s EWTX share price has surged by 7.97%, which has investors questioning if this is right time to sell.

Edgewise Therapeutics shares tumbled more than 20% Wednesday after the developmental drug company issued the results of its latest clinical trial.

Edgewise Therapeutics, Inc.’s EWTX share price has dipped by 15.24%, which has investors questioning if this is right time to ...

Fintel reports that on April 3, 2025, Scotiabank downgraded their outlook for Edgewise Therapeutics (NasdaqGS:EWTX) from ...

In this article, we are going to take a look at where Edgewise Therapeutics, Inc. (NASDAQ:EWTX) stands against other stocks that insiders bought in April after Trump’s tariff rollout.

In this article, we are going to take a look at where Edgewise Therapeutics, Inc. (NASDAQ:EWTX) stands against other stocks ...

We recently published a list of 10 Unstoppable Stocks That Could Double Your Money. In this article, we are going to take a look at where Edgewise Therapeutics, Inc. (NASDAQ:EWTX) stands against other ...

Hinterhaus Productions via Getty Images Shares of Edgewise Therapeutics fell sharply Wednesday after the company released data for its latest clinical trial. The drug accomplished its main goal ...

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) – Research analysts at Wedbush decreased their Q1 2025 earnings estimates for shares of Edgewise Therapeutics in a research note issued ...

April 2, 2025 /PRNewswire/ -- Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced positive top-line data of EDG-7500 from the Phase 2 ...

The last time I wrote about Edgewise Therapeutics, Inc. (NASDAQ:EWTX) it was in a Seeking Alpha article entitled "Edgewise: Remains A Buy After Latest Becker Muscular Dystrophy Data." In the ...